SEATTLE (AP) _ Omeros Corporation (OMER) on Monday reported a loss of $35.1 million in its first quarter.
On a per-share basis, the Seattle-based company said it had a loss of 57 cents. Losses, adjusted for non-recurring costs, came to 50 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.
The drug developer posted revenue of $21.1 million in the period.
Omeros shares have risen 24% since the beginning of the year. In the final minutes of trading on Monday, shares hit $17.69, a climb of 11% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News